Stephen Maebius and Jennie Zheng Contribute to Article on Next-Gen Bioprinted Products
14 March 2023
IEEE Pulse
Foley & Lardner LLP Partner Stephen Maebius and Patent Agent Jennie Zheng contributed to an article in IEEE Pulse titled, “ Next Generation Bioprinted Products: Products of Nature or Patentable Innovation ” in Volume 14, Issue 1 of the publication.
The authors describe the process of bioprinting, and its present use cases to generate a diverse range of products like ear and bone and its future potential across further complex matters, including a wide range of human organs. They then discuss the many aspects of bioprinting that are patent eligible, and examine potential strategies that may allow U.S. patents to be granted even on the end products.
People
Related News
13 January 2025
In the News
Matthew Krueger Assesses Government Health Care Enforcement Focuses for 2025
Foley & Lardner LLP partner Matthew Krueger assessed several key government health care enforcement targets for the year ahead in the Report on Medicare Compliance article, "Outlook 2025: Look for MA Cases Based on Claim Denials; Incoming DOJ May Tweak Guidance," published by the Health Care Compliance Association.
13 January 2025
In the News
Aaron Maguregui on HHS Cybersecurity Revamp – 'Going to be added costs across the board'
Foley & Lardner LLP partner Aaron Maguregui assessed the U.S. Department of Health and Human Services' (HHS) proposed overhaul of its cybersecurity rules in the Bloomberg Law article, "Health Supply-Chain Hacks Targeted by HHS Cybersecurity Rule."
13 January 2025
In the News
Judith Waltz Describes Potential Health Policy Changes Under New Administration
Foley & Lardner LLP partner Judith Waltz commented on potential health policy changes under the incoming presidential administration in the Report on Medicare Compliance article, "Outlook 2025: Disruption Is Expected, Along With More OIG Guidance, Payment Changes," published by the Health Care Compliance Association.